All Stories

  1. Relationships among material plasticity, tablet brittleness, and tensile strength
  2. Expert insights into the development of large-volume subcutaneous drugs with permeation enhancers: A survey examining challenges, alternatives, and future directions
  3. A review of the state-of-the-art: progress in ultrasonic and acoustic techniques for quality assessment in the development and manufacturing of oral solid dosage forms − Part I: theoretical foundations and principles
  4. A Comparative Study of the Tabletability of Amorphous and Crystalline Forms of Organic Drugs
  5. Tabletability Flip in Dry Granulated Systems
  6. An integrated material-sparing method for determining dilution potential of direct compression tablet fillers
  7. Discerning excipient functionality: Lubricants vs. anti-adherents
  8. Predicting the tabletability of binary powder mixtures from that of individual components
  9. A Global Analysis of the Mechanical Properties of Organic Glasses Below Tg
  10. An integrated material-sparing method for determining dilution potential of direct compression tablet fillers
  11. Unveiling the Structure of Anhydrous Sodium Valproate with 3D Electron Diffraction and a Facile Sample Preparation Workflow
  12. Modulating Milling-Induced Amorphization Propensity of Drug Crystals by Cocrystallization
  13. Unveiling the Structure of Anhydrous Sodium Valproate with 3D Electron Diffraction and a Facile Sample Preparation Workflow
  14. Elucidating critical factors driving the tabletability flip phenomenon
  15. Decreased Crystal Plasticity by Solvation – the Case of Levofloxacin Acesulfame
  16. Preparation and solid-state characterization of two novel berberine chloride cocrystals with benzene derivatives
  17. Some properties and applications of the tabletability equation
  18. Impact of solid content on the bulk properties of lyophilized powders
  19. Simultaneously improving tabletability and solubility of diclofenac by cocrystallization with picolinamide
  20. Direct compression tablet formulation of trimetazidine through systematic screening of oxalate salts
  21. Efficient Development of High Drug Loaded Posaconazole Tablets Enabled by Amorphous Solid Dispersion
  22. Impact of route of particle engineering on dissolution performance of posaconazole
  23. Delaying the first nucleation event of amorphous solid dispersions above the polymer overlap concentration (c*): PVP and PVPVA in posaconazole
  24. Efficient determination of critical water activity and classification of hydrate-anhydrate stability relationship
  25. Miscibility of amorphous solid dispersions: A rheological and solid-state NMR spectroscopy study
  26. How elastically flexible can molecular crystals be? – a new record
  27. An evaluation of six techniques for measuring porosity of ribbons produced by roller compaction
  28. Crystal structure-mechanical property relationship in succinic acid and L- alanine probed by nanoindentation
  29. Plasticization of a stiff pharmaceutical solid for better tabletability via cocrystallization: Shape synthons as supramolecular protecting groups
  30. Advancing the Harmonization of Biopredictive Methodologies through the Product Quality Research Institute (PQRI) Consortium: Biopredictive Dissolution of Dipyridamole Tablets
  31. A systematic comparison of four pharmacopoeial methods for measuring powder flowability
  32. Surface Engineering of the Mechanical Properties of Molecular Crystals via an Atomistic Model for Computing the Facet Stress Response of Solids
  33. Understanding the roles of compaction pressure and crystal hardness on powder tabletability through bonding area – Bonding strength interplay
  34. Surface Engineering of the Mechanical Properties of Molecular Crystals via an Atomistic Model for Computing the Facet Stress Response of Solids
  35. Surface Engineering of the Mechanical Properties of Molecular Crystals via an Atomistic Model for Computing the Facet Stress Response of Solids
  36. Relative Bioavailability Assessment of Solid Forms by An Artificial Stomach and Duodenum Apparatus
  37. A strategy to optimize precompression pressure for tablet manufacturing based on in-die elastic recovery
  38. A new insight into the mechanism of the tabletability flip phenomenon
  39. Cocrystallization improves the tabletability of ligustrazine despite a reduction in plasticity
  40. Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid
  41. Tuning Caco-2 permeability by cocrystallization: Insights from molecular dynamics simulation
  42. Worsened punch sticking by external lubrication with magnesium stearate
  43. Effect of drug loading and relative humidity on the mechanical properties and tableting performance of Celecoxib–PVP/VA 64 amorphous solid dispersions
  44. The ubiquity of the tabletability flip phenomenon
  45. Correction: Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets
  46. Enabling direct compression tablet formulation of celecoxib by simultaneously eliminating punch sticking, improving manufacturability, and enhancing dissolution through co-processing with a mesoporous carrier
  47. Understanding the role of magnesium stearate in lowering punch sticking propensity of drugs during compression
  48. Modulating Pharmaceutical Properties of Berberine Chloride through Cocrystallization with Benzendiol Isomers
  49. Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets
  50. An approach for predicting the true density of powders based on in-die compression data
  51. A material-sparing simplified buoyancy method for determining the true density of solids
  52. Structural Origin of Anisotropic Thermal Expansion of Molecular Crystals and Implication for the Density Rule Probed with Four ROY Polymorphs
  53. Magnesium stearate surface coverage on tablets and drug crystals: Insights from SEM-EDS elemental mapping
  54. A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions
  55. Mechanical properties and peculiarities of molecular crystals
  56. Professor Raj Suryanarayanan: Scientist, Educator, Mentor, Family Man and Giant in Pharmaceutical Research
  57. A critical examination of three-point bending for determining Young’s modulus
  58. Crystal and Particle Engineering – An Indispensable Tool for Developing and Manufacturing Quality Pharmaceutical Products
  59. Varied Bulk Powder Properties of Micro-Sized API within Size Specifications as a Result of Particle Engineering Methods
  60. Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance
  61. An extended macroindentation method for determining the hardness of poorly compressible materials
  62. A powder tabletability equation
  63. Profound effects of gastric secretion rate variations on the precipitation of erlotinib in duodenum – An in vitro investigation
  64. Nanomechanical testing in drug delivery: Theory, applications, and emerging trends
  65. Complexation with aromatic carboxylic acids expands the solid-state landscape of berberine
  66. Mechanisms of Crystal Plasticization by Lattice Water
  67. Air entrapment during tablet compression – Diagnosis, impact on tableting performance, and mitigation strategies
  68. Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization
  69. Effects of shear cell size on flowability of powders measured using a ring shear tester
  70. Formulation strategies for mitigating dissolution reduction of p-aminobenzoic acid by sodium lauryl sulfate through diffusion layer modulation
  71. Stress transmission coefficient is a reliable and robust parameter for quantifying powder plasticity
  72. Profoundly improved photostability of dimetronidazole by cocrystallization
  73. Efficient development of sorafenib tablets with improved oral bioavailability enabled by coprecipitated amorphous solid dispersion
  74. Mean yield pressure from the in-die Heckel analysis is a reliable plasticity parameter
  75. Exceptional Powder Tabletability of Elastically Flexible Crystals
  76. Pharmaceutical Lauryl Sulfate Salts: Prevalence, Formation Rules, and Formulation Implications
  77. An Elusive Drug–Drug Cocrystal Prepared Using a Heteroseeding Strategy
  78. Effect of Lipidic Excipients on the Particle Properties and Aerosol Performance of High Drug Load Spray Dried Particles for Inhalation
  79. Effects of compaction and storage conditions on stability of intravenous immunoglobulin – Implication on developing oral tablets of biologics
  80. Drug–Drug Cocrystallization Simultaneously Improves Pharmaceutical Properties of Genistein and Ligustrazine
  81. Improving the Solubility, Dissolution, and Bioavailability of Metronidazole via Cocrystallization with Ethyl Gallate
  82. Nanomechanical mapping and strain rate sensitivity of microcrystalline cellulose
  83. Novel Salt-Cocrystals of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd–Even Alternation in Physicochemical Properties
  84. Direct compression tablet formulation of celecoxib enabled with a pharmaceutical solvate
  85. How Does the Dissimilarity of Screw Geometry Impact Twin-screw Melt Granulation?
  86. Low-dose salinomycin inhibits breast cancer metastasis by repolarizing tumor hijacked macrophages toward the M1 phenotype
  87. Modulation of the powder properties of lamotrigine by crystal forms
  88. Structural Origins of Elastic and 2D Plastic Flexibility of Molecular Crystals Investigated with Two Polymorphs of Conformationally Rigid Coumarin
  89. Sweet Sulfamethazine Acesulfamate Crystals with Improved Compaction Property
  90. Mechanically responsive crystalline materials
  91. Reversible facile single-crystal-to-single-crystal polymorphic transition accompanied by unit cell volume expansion and twinning
  92. Cocrystal engineering of pharmaceutical solids: therapeutic potential and challenges
  93. The impact of solid-state form, water content and surface area of magnesium stearate on lubrication efficiency, tabletability, and dissolution
  94. Tabletability Flip – Role of Bonding Area and Bonding Strength Interplay
  95. Structural Insights into the Distinct Solid-State Properties and Interconversion of Celecoxib N-Methyl-2-pyrrolidone Solvates
  96. Discovery, Characterization, and Pharmaceutical Applications of Two Loratadine–Oxalic Acid Cocrystals
  97. The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach
  98. Development of piroxicam mini-tablets enabled by spherical cocrystallization
  99. Profound tabletability deterioration of microcrystalline cellulose by magnesium stearate
  100. Novel Quasi-Emulsion Solvent Diffusion-Based Spherical Cocrystallization Strategy for Simultaneously Improving the Manufacturability and Dissolution of Indomethacin
  101. Effect of Hydroxypropyl Cellulose Level on Twin-Screw Melt Granulation of Acetaminophen
  102. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal– a QbD Approach
  103. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets
  104. Molecular Origin of the Distinct Tabletability of Loratadine and Desloratadine: Role of the Bonding Area – Bonding Strength Interplay
  105. Intermolecular interactions and disorder in six isostructural celecoxib solvates
  106. Mitigating Punch Sticking Propensity of Celecoxib by Cocrystallization: An Integrated Computational and Experimental Approach
  107. Conformation Directed Interaction Anisotropy Leading to Distinct Bending Behaviors of Two ROY Polymorphs
  108. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies
  109. Reduction of Punch-Sticking Propensity of Celecoxib by Spherical Crystallization via Polymer Assisted Quasi-Emulsion Solvent Diffusion
  110. Toward a Molecular Understanding of the Impact of Crystal Size and Shape on Punch Sticking
  111. Simultaneous taste-masking and oral bioavailability enhancement of Ligustrazine by forming sweet salts
  112. Extended Release of Highly Water Soluble Isoniazid Attained through Cocrystallization with Curcumin
  113. Reducing the Sublimation Tendency of Ligustrazine through Salt Formation
  114. The role of the screw profile on granular structure and mixing efficiency of a high-dose hydrophobic drug formulation during twin screw wet granulation
  115. A systematic evaluation of poloxamers as tablet lubricants
  116. Interfacial bonding in formulated bilayer tablets
  117. A material-saving and robust approach for obtaining accurate out-of-die powder compressibility
  118. Molecular Interpretation of Mechanical Behavior in Four Basic Crystal Packing of Isoniazid with Homologous Cocrystal Formers
  119. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods
  120. Expedited Investigation of Powder Caking Aided by Rapid 3D Prototyping of Testing Devices
  121. The landscape of mechanical properties of molecular crystals
  122. Workshop Report: USP Workshop on Advancements in In Vitro Performance Testing of Drug Products
  123. Crystallographic and Energetic Insights into Reduced Dissolution and Physical Stability of a Drug–Surfactant Salt: The Case of Norfloxacin Lauryl Sulfate
  124. Molecular Interpretation of the Compaction Performance and Mechanical Properties of Caffeine Cocrystals: A Polymorphic Study
  125. Improving Powder Characteristics by Surface Modification Using Atomic Layer Deposition
  126. Correction to Fast Determination of Phase Stability of Hydrates Using Intrinsic Dissolution Rate Measurements
  127. Effect of particle size on interfacial bonding strength of bilayer tablets
  128. Structural Features of Sulfamethizole and Its Cocrystals: Beauty Within
  129. Fast Determination of Phase Stability of Hydrates Using Intrinsic Dissolution Rate Measurements
  130. Insights into the effect of compaction pressure and material properties on interfacial bonding strength of bilayer tablets
  131. Relationship between hydrate stability and accuracy of true density measured by helium pycnometry
  132. Minimum Interfacial Bonding Strength for Bilayer Tablets Determined Using a Survival Test
  133. Correction to Crystal Growth of Celecoxib from Amorphous State: Polymorphism, Growth Mechanism, and Kinetics
  134. Single-Crystal Plasticity Defies Bulk-Phase Mechanics in Isoniazid Cocrystals with Analogous Coformers
  135. Tableting performance of various mannitol and lactose grades assessed by compaction simulation and chemometrical analysis
  136. Crystal growth of celecoxib from amorphous state – polymorphism, growth mechanism, and kinetics
  137. Reduced Punch Sticking Propensity of Acesulfame by Salt Formation: Role of Crystal Mechanical Property and Surface Chemistry
  138. Twistable Pharmaceutical Crystal Exhibiting Exceptional Plasticity and Tabletability
  139. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer
  140. Effect of screw profile and processing conditions on physical transformation and chemical degradation of gabapentin during twin-screw melt granulation
  141. Direct Compression Tablet Containing 99% Active Ingredient—A Tale of Spherical Crystallization
  142. Cocrystal Engineering of Itraconazole with Suberic Acid via Rotary Evaporation and Spray Drying
  143. Computational Techniques for Predicting Mechanical Properties of Organic Crystals: A Systematic Evaluation
  144. Profoundly Improved Plasticity and Tabletability of Griseofulvin by in Situ Solvation and Desolvation during Spherical Crystallization
  145. Spherical Cocrystallization—An Enabling Technology for the Development of High Dose Direct Compression Tablets of Poorly Soluble Drugs
  146. Effects of thermal binders on chemical stabilities and tabletability of gabapentin granules prepared by twin-screw melt granulation
  147. Effects of Water on Powder Flowability of Diverse Powders Assessed by Complimentary Techniques
  148. Exceptionally Elastic Single-Component Pharmaceutical Crystals
  149. Developing Biologics Tablets: The Effects of Compression on the Structure and Stability of Bovine Serum Albumin and Lysozyme
  150. Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin
  151. Robust bulk preparation and characterization of sulfamethazine and saccharine salt and cocrystal polymorphs
  152. A platform direct compression formulation for low dose sustained-release tablets enabled by a dual particle engineering approach
  153. Improving solid-state properties of berberine chloride through forming a salt cocrystal with citric acid
  154. Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate
  155. Proportionality between powder cohesion and unconfined yield strength from shear cell testing
  156. Cubosomes with surface cross-linked chitosan exhibit sustained release and bioavailability enhancement for vinpocetine
  157. Structures and Properties of Granules Prepared By High Shear Wet Granulation
  158. A systematic evaluation of dual functionality of sodium lauryl sulfate as a tablet lubricant and wetting enhancer
  159. Mechanical Properties
  160. Cocrystallization of Curcumin with Benzenediols and Benzenetriols via Rapid Solvent Removal
  161. Preparation, Characterization, and Formulation Development of Drug–Drug Protic Ionic Liquids of Diphenhydramine with Ibuprofen and Naproxen
  162. Ribbon density and milling parameters that determine fines fraction in a dry granulation
  163. Comparative analyses of flow and compaction properties of diverse mannitol and lactose grades
  164. Anion Exchange Reaction for Preparing Acesulfame Solid Forms
  165. Relating the tableting behavior of piroxicam polytypes to their crystal structures using energy-vector models
  166. Systematic evaluation of common lubricants for optimal use in tablet formulation
  167. The relationship among tensile strength, Young's modulus, and indentation hardness of pharmaceutical compacts
  168. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression
  169. Modulating Sticking Propensity of Pharmaceuticals Through Excipient Selection in a Direct Compression Tablet Formulation
  170. A mesoporous silica based platform to enable tablet formulations of low dose drugs by direct compression
  171. Identifying Slip Planes in Organic Polymorphs by Combined Energy Framework Calculations and Topology Analysis
  172. Reduced interface spin polarization by antiferromagnetically coupled Mn segregated to the Co2MnSi /GaAs (001) interface
  173. Lack of dependence of mechanical properties of baicalein cocrystals on those of the constituent components
  174. Subsurface nucleation of supercooled acetaminophen
  175. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer
  176. Relationships among Crystal Structures, Mechanical Properties, and Tableting Performance Probed Using Four Salts of Diphenhydramine
  177. Dependence of Friability on Tablet Mechanical Properties and a Predictive Approach for Binary Mixtures
  178. Expedited development of a high dose orally disintegrating metformin tablet enabled by sweet salt formation with acesulfame
  179. The suitability of common compressibility equations for characterizing plasticity of diverse powders
  180. Tablets of multi-unit pellet system for controlled drug delivery
  181. Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering
  182. Ribbon thickness influences fine generation during dry granulation
  183. Dependence of Punch Sticking on Compaction Pressure—Roles of Particle Deformability and Tablet Tensile Strength
  184. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression
  185. Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin
  186. Superior Plasticity and Tabletability of Theophylline Monohydrate
  187. Gaining insight into tablet capping tendency from compaction simulation
  188. Tensile and shear methods for measuring strength of bilayer tablets
  189. Powder properties and compaction parameters that influence punch sticking propensity of pharmaceuticals
  190. Lubrication with magnesium stearate increases tablet brittleness
  191. A top coating strategy with highly bonding polymers to enable direct tableting of multiple unit pellet system (MUPS)
  192. Mechanical Properties and Tableting Behavior of Amorphous Solid Dispersions
  193. Mechanism and Kinetics of Punch Sticking of Pharmaceuticals
  194. Preparation of slab-shaped lactose carrier particles for dry powder inhalers by air jet milling
  195. Self-templating accelerates precipitation of carbamazepine dihydrate during the dissolution of a soluble carbamazepine cocrystal
  196. The phenomenon of tablet flashing — Its impact on tableting data analysis and a method to eliminate it
  197. Harvesting Potential Dissolution Advantages of Soluble Cocrystals by Depressing Precipitation Using the Common Coformer Effect
  198. Process optimization of dry granulation based tableting line: Extracting physical material characteristics from granules, ribbons and tablets using near-IR (NIR) spectroscopic measurement
  199. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression
  200. Solid-state characterization of optically pure (+)Dihydromyricetin extracted from Ampelopsis grossedentata leaves
  201. Enhancing Bioavailability of Dihydromyricetin through Inhibiting Precipitation of Soluble Cocrystals by a Crystallization Inhibitor
  202. A classification system for tableting behaviors of binary powder mixtures
  203. Microstructure of Tablet—Pharmaceutical Significance, Assessment, and Engineering
  204. Resveratrol cocrystals with enhanced solubility and tabletability
  205. Macroindentation hardness measurement—Modernization and applications
  206. Enabling the Tablet Product Development of 5-Fluorocytosine by Conjugate Acid Base Cocrystals
  207. Mini review: Mechanisms to the loss of tabletability by dry granulation
  208. Sweet Berberine
  209. Quantifying effects of moisture content on flow properties of microcrystalline cellulose using a ring shear tester
  210. A critical Examination of the Phenomenon of Bonding Area - Bonding Strength Interplay in Powder Tableting
  211. From molecular salt to pseudo CAB cocrystal: Expanding solid-state landscape of carboxylic acids based on charge-assisted COOH⋯COO− hydrogen bonds
  212. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance
  213. Dependence of tablet brittleness on tensile strength and porosity
  214. Tabletability Modulation Through Surface Engineering
  215. Development of highly stabilized curcumin nanoparticles by flash nanoprecipitation and lyophilization
  216. Dependence of ejection force on tableting speed—A compaction simulation study
  217. A new tablet brittleness index
  218. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting
  219. Validation and applications of an expedited tablet friability method
  220. Correlation Among Crystal Structure, Mechanical Behavior, and Tabletability in the Co-Crystals of Vanillin Isomers
  221. Designing Micellar Nanocarriers with Improved Drug Loading and Stability Based on Solubility Parameter
  222. Significant Expansion of the Solid State Landscape of Salicylic Acid Based on Charge-Assisted Hydrogen Bonding Interactions
  223. Solvent and additive interactions as determinants in the nucleation pathway: general discussion
  224. Nucleation in complex multi-component and multi-phase systems: general discussion
  225. Effect of Heating Rate and Kinetic Model Selection on Activation Energy of Nonisothermal Crystallization of Amorphous Felodipine
  226. Kinetic Entrapment of a Hidden Curcumin Cocrystal with Phloroglucinol
  227. Effect of Crystal Habit on Intrinsic Dissolution Behavior of Celecoxib Due to Differential Wettability
  228. Assessment of the relative performance of a confined impinging jets mixer and a multi-inlet vortex mixer for curcumin nanoparticle production
  229. Design and Preparation of a 4:1 Lamivudine–Oxalic Acid CAB Cocrystal for Improving the Lamivudine Purification Process
  230. Origin of Deteriorated Crystal Plasticity and Compaction Properties of a 1:1 Cocrystal between Piroxicam and Saccharin
  231. A Formulation Strategy for Solving the Overgranulation Problem in High Shear Wet Granulation
  232. Enabling Tablet Product Development of 5-Fluorocytosine Through Integrated Crystal and Particle Engineering
  233. Evolution of Structure and Properties of Granules Containing Microcrystalline Cellulose and Polyvinylpyrrolidone During High-Shear Wet Granulation
  234. Improving manufacturability of an ibuprofen powder blend by surface coating with silica nanoparticles
  235. Enabling direct compression of formulated Danshen powder by surface engineering
  236. Impact of Crystal Habit on Biopharmaceutical Performance of Celecoxib
  237. Design, Synthesis, and Characterization of New 5-Fluorocytosine Salts
  238. A Pitfall in Analyzing Powder Compatibility Data Using Nonlinear Regression
  239. Protonation of Cytosine: Cytosinium vs Hemicytosinium Duplexes
  240. Synthon preference in O-protonated amide crystals – dominance of short strong hydrogen bonds
  241. Improved solid-state stability of salts by cocrystallization between conjugate acid–base pairs
  242. Cocrystallization for successful drug delivery
  243. Preparation and Characterization of Surface-Engineered Coarse Microcrystalline Cellulose Through Dry Coating with Silica Nanoparticles
  244. Correction for Polymorphs, Salts and Cocrystals: What’s in a Name?
  245. Probing Interfaces between Pharmaceutical Crystals and Polymers by Neutron Reflectometry
  246. Polymorphs, Salts, and Cocrystals: What’s in a Name?
  247. Do not confuse hydrogen chloride with hydrochloric acid!
  248. Simultaneously Improving the Mechanical Properties, Dissolution Performance, and Hygroscopicity of Ibuprofen and Flurbiprofen by Cocrystallization with Nicotinamide
  249. Ionized form of acetaminophen with improved compaction properties
  250. Design and synthesis of solid state structures with conjugate acid–base pair interactions
  251. Direct correlation among crystal structure, mechanical behaviour and tabletability in a trimorphic molecular compound
  252. Origin of Two Modes of Non-isothermal Crystallization of Glasses Produced by Milling
  253. Profoundly improving flow properties of a cohesive cellulose powder by surface coating with nano‐silica through comilling
  254. Reproducibility of flow properties of microcrystalline cellulose — Avicel PH102
  255. Initial moisture content in raw material can profoundly influence high shear wet granulation process
  256. Overcoming Poor Tabletability of Pharmaceutical Crystals by Surface Modification
  257. Massing in high shear wet granulation can simultaneously improve powder flow and deteriorate powder compaction: A double-edged sword
  258. Origin of profound changes in powder properties during wetting and nucleation stages of high-shear wet granulation of microcrystalline cellulose
  259. Understanding Size Enlargement and Hardening of Granules on Tabletability of Unlubricated Granules Prepared by Dry Granulation
  260. Decoding Powder Tabletability: Roles of Particle Adhesion and Plasticity
  261. The Manufacture of Low-Dose Oral Solid Dosage Form to Support Early Clinical Studies Using an Automated Micro-Filing System
  262. Transforming Powder Mechanical Properties by Core/Shell Structure: Compressible Sand
  263. Roles of Granule Size in Over-Granulation During High Shear Wet Granulation
  264. Setting the bar for powder flow properties in successful high speed tableting
  265. Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1 : 1 co-crystal
  266. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles
  267. Improving Powder Flow Properties of Citric Acid by Crystal Hydration
  268. Materials Science Tetrahedron—A Useful Tool for Pharmaceutical Research and Development
  269. Development of a high drug load tablet formulation based on assessment of powder manufacturability: Moving towards quality by design
  270. Quantifying Effects of Particulate Properties on Powder Flow Properties Using a Ring Shear Tester
  271. On the Identification of Slip Planes in Organic Crystals Based on Attachment Energy Calculation
  272. Improving Mechanical Properties of Caffeine and Methyl Gallate Crystals by Cocrystallization
  273. Mechanism of moisture induced variations in true density and compaction properties of microcrystalline cellulose
  274. On the mechanism of reduced tabletability of granules prepared by roller compaction
  275. Influence of crystal structure on the tableting properties of n‐alkyl 4‐hydroxybenzoate esters (parabens)
  276. Thermal Expansion of Organic Crystals and Precision of Calculated Crystal Density: A Survey of Cambridge Crystal Database
  277. Insensitivity of Compaction Properties of Brittle Granules to Size Enlargement by Roller Compaction
  278. A material-sparing method for simultaneous determination of true density and powder compaction properties—Aspartame as an example
  279. Solid-state properties and crystallization behavior of PHA-739521 polymorphs
  280. Reduced tabletability of roller compacted granules as a result of granule size enlargement
  281. True Density of Microcrystalline Cellulose
  282. A Study of Sulfamerazine Single Crystals Using Atomic Force Microscopy, Transmission Light Microscopy, and Raman Spectroscopy
  283. Quantifying Errors in Tableting Data Analysis Using the Ryshkewitch Equation Due to Inaccurate True Density
  284. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction
  285. A Novel Method for Deriving True Density of Pharmaceutical Solids Including Hydrates and Water-Containing Powders
  286. Improved Tableting Properties of p-Hydroxybenzoic Acid by Water of Crystallization: A Molecular Insight
  287. Theophylline monohydrate
  288. Influence of Crystal Shape on the Tableting Performance of L‐Lysine Monohydrochloride Dihydrate
  289. Influence of crystal shape on the tableting performance of L‐lysine monohydrochloride dihydrate
  290. Influence of crystal shape on the tableting performance of L-lysine monohydrochloride dihydrate
  291. Effects of initial particle size on the tableting properties of l-lysine monohydrochloride dihydrate powder
  292. Influence of Elastic Deformation of Particles on Heckel Analysis